Concepts (116)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Veins | 5 | 2015 | 761 | 0.380 |
Why?
|
| Atrial Fibrillation | 10 | 2015 | 5034 | 0.280 |
Why?
|
| Catheter Ablation | 7 | 2015 | 2758 | 0.270 |
Why?
|
| Anti-Arrhythmia Agents | 3 | 2007 | 789 | 0.220 |
Why?
|
| Heart Block | 2 | 2005 | 410 | 0.210 |
Why?
|
| Tachycardia, Atrioventricular Nodal Reentry | 1 | 2003 | 137 | 0.210 |
Why?
|
| Blood Chemical Analysis | 1 | 2003 | 440 | 0.190 |
Why?
|
| Troponin I | 1 | 2003 | 619 | 0.160 |
Why?
|
| Magnetic Resonance Angiography | 3 | 2015 | 1442 | 0.150 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2000 | 585 | 0.150 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 1998 | 369 | 0.150 |
Why?
|
| Electrocardiography | 4 | 2003 | 6442 | 0.140 |
Why?
|
| Adrenalectomy | 1 | 1998 | 341 | 0.140 |
Why?
|
| Carrier Proteins | 2 | 1999 | 5021 | 0.130 |
Why?
|
| Phlebography | 1 | 2015 | 333 | 0.120 |
Why?
|
| Astrocytes | 1 | 1999 | 1270 | 0.100 |
Why?
|
| Blood Coagulation | 2 | 2010 | 1127 | 0.100 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2000 | 2268 | 0.090 |
Why?
|
| International Normalized Ratio | 1 | 2010 | 367 | 0.080 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 2 | 2007 | 493 | 0.070 |
Why?
|
| RNA, Messenger | 2 | 1999 | 13033 | 0.070 |
Why?
|
| Gene Expression | 1 | 1999 | 7799 | 0.070 |
Why?
|
| Transcription, Genetic | 1 | 1999 | 7722 | 0.060 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 1 | 2005 | 66 | 0.060 |
Why?
|
| Myocardial Infarction | 2 | 2003 | 11727 | 0.060 |
Why?
|
| Drug Monitoring | 1 | 2010 | 956 | 0.060 |
Why?
|
| Autoanalysis | 1 | 2003 | 72 | 0.060 |
Why?
|
| Stress, Psychological | 1 | 1998 | 4245 | 0.060 |
Why?
|
| Cardiac Volume | 1 | 2004 | 210 | 0.060 |
Why?
|
| Heparin | 1 | 2010 | 1637 | 0.060 |
Why?
|
| Tachycardia | 1 | 2004 | 619 | 0.050 |
Why?
|
| False Positive Reactions | 1 | 2003 | 981 | 0.050 |
Why?
|
| Contrast Media | 2 | 2004 | 5300 | 0.050 |
Why?
|
| Gadolinium DTPA | 1 | 2004 | 836 | 0.050 |
Why?
|
| Radiographic Image Enhancement | 1 | 2004 | 885 | 0.040 |
Why?
|
| Heart Conduction System | 1 | 2004 | 1047 | 0.040 |
Why?
|
| Peptidylprolyl Isomerase | 1 | 1998 | 105 | 0.040 |
Why?
|
| Hemorrhage | 1 | 2010 | 3461 | 0.040 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1999 | 821 | 0.040 |
Why?
|
| Ribonucleases | 1 | 1998 | 287 | 0.040 |
Why?
|
| Corticosterone | 1 | 1998 | 310 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 2 | 1999 | 8301 | 0.040 |
Why?
|
| DNA Probes | 1 | 1998 | 560 | 0.040 |
Why?
|
| Heart Atria | 1 | 2004 | 1357 | 0.040 |
Why?
|
| Computer-Assisted Instruction | 1 | 2001 | 365 | 0.040 |
Why?
|
| Restraint, Physical | 1 | 1998 | 193 | 0.040 |
Why?
|
| Health Resources | 1 | 2003 | 911 | 0.040 |
Why?
|
| RNA, Catalytic | 1 | 1997 | 50 | 0.040 |
Why?
|
| Thromboembolism | 1 | 2003 | 986 | 0.040 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 1998 | 648 | 0.040 |
Why?
|
| RNA, Fungal | 1 | 1997 | 164 | 0.030 |
Why?
|
| Ventricular Remodeling | 1 | 2003 | 1224 | 0.030 |
Why?
|
| RNA Precursors | 1 | 1997 | 208 | 0.030 |
Why?
|
| Anticoagulants | 1 | 2010 | 4599 | 0.030 |
Why?
|
| Endoribonucleases | 1 | 1997 | 229 | 0.030 |
Why?
|
| Costs and Cost Analysis | 1 | 2000 | 1681 | 0.030 |
Why?
|
| RNA, Transfer | 1 | 1997 | 316 | 0.030 |
Why?
|
| Educational Measurement | 1 | 2001 | 1210 | 0.030 |
Why?
|
| Nucleic Acid Conformation | 1 | 1997 | 913 | 0.030 |
Why?
|
| Disease Management | 1 | 2003 | 2459 | 0.030 |
Why?
|
| Rats | 2 | 1999 | 24260 | 0.030 |
Why?
|
| Dexamethasone | 1 | 1999 | 1951 | 0.030 |
Why?
|
| Heart Rate | 1 | 2003 | 4091 | 0.030 |
Why?
|
| Time Factors | 4 | 2015 | 40075 | 0.030 |
Why?
|
| Emergency Medical Services | 1 | 2003 | 1917 | 0.030 |
Why?
|
| Middle Aged | 10 | 2015 | 213383 | 0.020 |
Why?
|
| Treatment Outcome | 5 | 2015 | 63114 | 0.020 |
Why?
|
| Predictive Value of Tests | 3 | 2015 | 15076 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 1999 | 2107 | 0.020 |
Why?
|
| Humans | 15 | 2015 | 744343 | 0.020 |
Why?
|
| Incidence | 2 | 2003 | 20947 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2000 | 5391 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2010 | 23338 | 0.020 |
Why?
|
| Multivariate Analysis | 2 | 2015 | 12245 | 0.020 |
Why?
|
| Female | 11 | 2015 | 380194 | 0.020 |
Why?
|
| Male | 11 | 2015 | 350118 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2004 | 15540 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2003 | 7279 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2010 | 77449 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2004 | 39050 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 6538 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 3508 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 1999 | 19229 | 0.010 |
Why?
|
| Boston | 2 | 2010 | 9313 | 0.010 |
Why?
|
| Recurrence | 1 | 2015 | 8340 | 0.010 |
Why?
|
| Adult | 5 | 2015 | 214055 | 0.010 |
Why?
|
| Prospective Studies | 4 | 2015 | 53288 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2010 | 4933 | 0.010 |
Why?
|
| Warfarin | 1 | 2010 | 1496 | 0.010 |
Why?
|
| Risk Factors | 4 | 2015 | 72290 | 0.010 |
Why?
|
| Aged | 5 | 2010 | 163280 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2003 | 57776 | 0.010 |
Why?
|
| Diastole | 1 | 2004 | 791 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2010 | 6459 | 0.010 |
Why?
|
| Hospital Information Systems | 1 | 2001 | 395 | 0.010 |
Why?
|
| Observer Variation | 1 | 2004 | 2593 | 0.010 |
Why?
|
| Ribonuclease P | 1 | 1997 | 17 | 0.010 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2004 | 964 | 0.010 |
Why?
|
| Animals | 2 | 1999 | 168757 | 0.010 |
Why?
|
| Hydrolysis | 1 | 1997 | 682 | 0.010 |
Why?
|
| United States | 1 | 2003 | 69872 | 0.010 |
Why?
|
| Linear Models | 1 | 2004 | 5952 | 0.010 |
Why?
|
| Chest Pain | 1 | 2000 | 1114 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 1997 | 1801 | 0.010 |
Why?
|
| Ventricular Function, Left | 1 | 2004 | 3670 | 0.010 |
Why?
|
| Health Care Costs | 1 | 2003 | 3209 | 0.010 |
Why?
|
| Education, Medical | 1 | 2001 | 1721 | 0.010 |
Why?
|
| Internet | 1 | 2001 | 3064 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1997 | 2752 | 0.000 |
Why?
|
| Reproducibility of Results | 1 | 2004 | 19905 | 0.000 |
Why?
|
| Sensitivity and Specificity | 1 | 2000 | 14722 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 2000 | 12959 | 0.000 |
Why?
|
| Hospitalization | 1 | 2003 | 10262 | 0.000 |
Why?
|
| Algorithms | 1 | 2003 | 13881 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2005 | 40561 | 0.000 |
Why?
|
| Prognosis | 1 | 2000 | 29063 | 0.000 |
Why?
|
Concepts
(116)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(15)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_